Patent · US6436673B1 · B1 · US
Polynucleotides encoding a novel neuronal cell growth factor
- (11) Publication number
- US6436673B1
- (21) Application number
- US-9835898-A
- (22) Filing date
- 1998-06-16
- (30) Priority date
- 1996-04-08
- (43) Publication date
- 2002-08-20
- (45) Date of grant
- 2002-08-20
- (52) CPC
- (73) Assignee
- UNIV JOHNS HOPKINS MED
- (54) Title
- Polynucleotides encoding a novel neuronal cell growth factor
- (57) Abstract
A novel neuronal cell growth factor, neuronal-activity regulated pentraxin, Narp, is provided, as well as polynucleotides encoding Narp. Narp is useful for induction of dendritic neurite outgrowth as well as promotion of neuronal migration. Methods for treatment of subjects having a neuronal cell disorder, utilizing Narp of the invention, are also provided.
- Full text
- View on Google Patents
Claims (7)
- An isolated polynucleotide encoding a Narp polypeptide wherein the amino acid sequence of the polypeptide is set forth in SEQ ID NO:2.
- The isolated polynucleotide of claim 1, wherein the Narp nucleotide sequence is set forth in SEQ ID NO:1 (FIG. 1), and in SEQ ID NO:1 wherein T can also be U.
- A recombinant expression vector comprising a polynucleotide according to claim 1.
- The vector of claim 3, wherein the vector is a plasmid.
- The vector of claim 3, wherein the vector is a virus.
- An isolated host cell stably transformed with the vector of claim 3.
- A method for producing a neuronal cell growth factor comprising culturing host cells of claim 6 under conditions which allow expression of the polynucleotide sequence and isolating the growth factor.
Record as JSON
{
"publication_number": "US6436673B1",
"country": "US",
"kind": "B1",
"title": "Polynucleotides encoding a novel neuronal cell growth factor",
"abstract": "A novel neuronal cell growth factor, neuronal-activity regulated pentraxin, Narp, is provided, as well as polynucleotides encoding Narp. Narp is useful for induction of dendritic neurite outgrowth as well as promotion of neuronal migration. Methods for treatment of subjects having a neuronal cell disorder, utilizing Narp of the invention, are also provided.",
"claims": [
"1. An isolated polynucleotide encoding a Narp polypeptide wherein the amino acid sequence of the polypeptide is set forth in SEQ ID NO:2.",
"2. The isolated polynucleotide of claim 1, wherein the Narp nucleotide sequence is set forth in SEQ ID NO:1 (FIG. 1), and in SEQ ID NO:1 wherein T can also be U.",
"3. A recombinant expression vector comprising a polynucleotide according to claim 1.",
"4. The vector of claim 3, wherein the vector is a plasmid.",
"5. The vector of claim 3, wherein the vector is a virus.",
"6. An isolated host cell stably transformed with the vector of claim 3.",
"7. A method for producing a neuronal cell growth factor comprising culturing host cells of claim 6 under conditions which allow expression of the polynucleotide sequence and isolating the growth factor."
],
"cpc": [
"C07K 14/71",
"A61K 38/00",
"C12N 5/0619"
],
"assignees": [
"UNIV JOHNS HOPKINS MED"
],
"filing_date": "1998-06-16",
"publication_date": "2002-08-20",
"grant_date": "2002-08-20",
"priority_date": "1996-04-08",
"application_number": "US-9835898-A",
"family_id": "24531964"
}
Record 3,180 of 5,000 in Patents full text (MLC-0201). Request the full dataset.